W-L Listerine Anticaries Rinse Gingivitis Assessment Required - FDA
This article was originally published in The Rose Sheet
Executive Summary
Acceptance of plaque reduction as the sole outcome of an experimental gingivitis model designed to demonstrate the antiplaque/antigingivitis activities of Listerine mouthrinse would be "premature," FDA told Warner-Lambert in a recent letter.
You may also be interested in...
Listerine With Fluoride Development Continues With “Feedback” Meeting
Pfizer Consumer Healthcare plans to conduct a six-month clinical study involving at least 300 subjects to determine whether adding .02% sodium fluoride to the company's Listerine mouthrinse affects the antiplaque/ antigingivitis effectiveness of the product
Listerine With Fluoride Development Continues With “Feedback” Meeting
Pfizer Consumer Healthcare plans to conduct a six-month clinical study involving at least 300 subjects to determine whether adding .02% sodium fluoride to the company's Listerine mouthrinse affects the antiplaque/ antigingivitis effectiveness of the product
P&G Clairol Addition Fuels 13% Jump In Q2 Beauty Sales
Procter & Gamble's beauty segment sales jumped 13% to $2.06 bil. in the second quarter (ended Dec. 31), fueled by the addition of roughtly six weeks of Clairol revenue, the company reported in a 1Jan. 31 sales and earnings release